Andrew D. Blann
#152,520
Most Influential Person Across History
Andrew D. Blann's AcademicInfluence.com Rankings
Andrew D. Blannengineering Degrees
Engineering
#4411
Historical Rank
Biomedical Engineering
#158
Historical Rank
Download Badge
Engineering Philosophy
Andrew D. Blann's Degrees
- Doctorate Medicine Stanford University
Why Is Andrew D. Blann Influential?
(Suggest an Edit or Addition)Andrew D. Blann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis (1995) (1167)
- Platelet activation: assessment and quantification. (2001) (510)
- The adhesion molecule P-selectin and cardiovascular disease. (2003) (470)
- von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? (1997) (441)
- Circulating endothelial cells (2005) (396)
- Cancer and the prothrombotic state. (2002) (336)
- Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. (1999) (330)
- Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. (2004) (302)
- Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation (2011) (282)
- Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. (1999) (281)
- Circulating Endothelial Cell/Leukocyte Adhesion Molecules in Atherosclerosis (1994) (275)
- Hypothesis: is soluble P-selectin a new marker of platelet activation? (1997) (231)
- Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. (2001) (231)
- Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol (2006) (219)
- A RELIABLE MARKER OF ENDOTHELIAL CELL DYSFUNCTION: DOES IT EXIST? (1995) (218)
- Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. (2005) (218)
- Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. (2006) (216)
- Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. (1999) (211)
- Endothelial Dysfunction and Damage in Congestive Heart Failure: Relation of Flow-Mediated Dilation to Circulating Endothelial Cells, Plasma Indexes of Endothelial Damage, and Brain Natriuretic Peptide (2004) (208)
- Circulating endothelial cells in cardiovascular disease. (2006) (207)
- Abnormalities of Hemorheological, Endothelial, and Platelet Function in Patients With Chronic Heart Failure in Sinus Rhythm: Effects of Angiotensin-Converting Enzyme Inhibitor and &bgr;-Blocker Therapy (2001) (197)
- Soluble CD40 Ligand, Soluble P-Selectin, Interleukin-6, and Tissue Factor in Diabetes Mellitus: Relationships to Cardiovascular Disease and Risk Factor Intervention (2004) (195)
- Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years (2005) (186)
- Angiogenesis: basic pathophysiology and implications for disease. (2003) (186)
- Plasma Angiopoietin-1, Angiopoietin-2, Angiopoietin Receptor Tie-2, and Vascular Endothelial Growth Factor Levels in Acute Coronary Syndromes (2004) (185)
- Increased Levels of Soluble Adhesion Molecules in Type 2 (Non-Insulin Dependent) Diabetes mellitus Are Independent of Glycaemic Control (1994) (184)
- Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. (2002) (179)
- Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. (1997) (178)
- Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). (2004) (174)
- Soluble E-selectin in cardiovascular disease and its risk factors (2003) (169)
- Bleeding risks of antithrombotic therapy (2002) (168)
- von Willebrand factor and endothelial damage in essential hypertension. (1993) (160)
- Soluble P-selectin in Atherosclerosis: A Comparison with Endothelial Cell and Platelet Markers (1997) (160)
- Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. (2004) (158)
- Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. (2004) (157)
- Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. (2004) (156)
- ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. (2007) (152)
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). (2004) (149)
- Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. (2003) (149)
- Increased levels of the soluble adhesion molecule E‐selectin in essential hypertension (1994) (146)
- Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. (2001) (145)
- Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. (2001) (144)
- Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. (2001) (142)
- Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006 (2011) (141)
- Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. (2005) (139)
- Hemoxygenase-1 in cardiovascular disease. (2008) (138)
- Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy (2004) (136)
- Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. (2005) (136)
- Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. (2003) (135)
- von Willebrand factor and the endothelium in vascular disease. (1993) (134)
- Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. (2000) (127)
- Adverse Influence of Cigarette Smoking on the Endothelium (1993) (125)
- Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. (2001) (123)
- Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison (2006) (118)
- Plasma angiopoietin‐1, angiopoietin‐2 and Tie‐2 in breast and prostate cancer: a comparison with VEGF and Flt‐1 (2003) (118)
- Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis. (1997) (118)
- Circulating ICAM-1 and VCAM-1 in Peripheral Artery Disease and Hypercholesterolaemia: Relationship to the Location of Atherosclerotic Disease, Smoking, and in the Prediction of Adverse Events (1998) (118)
- The influence of acute smoking on leucocytes, platelets and the endothelium. (1998) (118)
- Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. (1996) (116)
- Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. (1993) (116)
- Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. (2007) (116)
- Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation. (2000) (113)
- Endothelial dysfunction: methods of assessment and application to hypertension. (2004) (112)
- Thrombin as a multi-functional enzyme (2011) (112)
- The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. (1998) (112)
- Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. (2007) (112)
- Soluble Adhesion Molecules and Endothelial Cell Damage in HIV Infected Patients (1997) (110)
- The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules (1996) (108)
- Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease (1997) (107)
- Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. (2000) (107)
- Does hypertension confer a prothrombotic state? Virchow's triad revisited. (2000) (107)
- High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene (2001) (106)
- An overview of antithrombotic therapy (2002) (105)
- Arterial and Venous Thrombosis in Cancer Patients (2011) (104)
- Platelet microparticles and soluble P selectin in peripheral artery disease: Relationship to extent of disease and platelet activation markers (2005) (104)
- A reliable plasma marker of platelet activation: Does it exist? (2002) (104)
- Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). (2003) (102)
- A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. (2000) (100)
- Assessment of endothelial damage and dysfunction: observations in relation to heart failure. (2003) (99)
- Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. (2016) (99)
- Prognostic value of increased soluble thrombomodulin and increased soluble E‐selectin in ischaemic heart disease (1997) (98)
- Prognostic value of interleukin‐6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure (2003) (97)
- Abnormal angiopoietins 1&2, angiopoietin receptor Tie‐2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub‐study of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT)] (2005) (97)
- Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor (2001) (97)
- Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay? (2007) (94)
- von Willebrand factor and its relevance to cardiovascular disorders. (1995) (93)
- Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project (2002) (92)
- Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma (2004) (92)
- Circulating microparticles: new insights into the biochemical basis of microparticle release and activity (2011) (91)
- Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. (1995) (91)
- Plasma markers of angiogenesis in pregnancy induced hypertension (2005) (90)
- High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. (2005) (88)
- Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke. (1999) (87)
- Pharmacological Modulation of Platelet Function in Hypertension (2003) (86)
- Increased soluble P‐selectin levels following deep venous thrombosis: cause or effect? (2000) (85)
- Von Willebrand Factor, Soluble P-Selectin, and Target Organ Damage in Hypertension: A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) (2002) (85)
- A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. (2002) (84)
- Circulating endothelial cells in acute ischaemic stroke (2005) (81)
- Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation. (2013) (81)
- Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. (2009) (81)
- Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. (2006) (80)
- Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke (2004) (80)
- Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0 (1999) (79)
- Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? (2000) (78)
- High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men (2005) (77)
- von Willebrand factor and soluble E‐selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis (1996) (77)
- Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. (1994) (76)
- Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor? (2002) (75)
- Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. (2007) (74)
- Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis (2003) (74)
- Platelet P-Selectin Levels in Relation to Plasma Soluble P-Selectin and &bgr;-Thromboglobulin Levels in Atrial Fibrillation (2002) (73)
- Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients (2010) (73)
- Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade (2004) (72)
- A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation. (2002) (72)
- A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis. (2000) (72)
- Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease (1996) (70)
- A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. (2000) (70)
- Assessment of Endothelial Dysfunction: Focus on Atherothrombotic Disease (2003) (69)
- A contemporary view on endothelial function in heart failure (2012) (69)
- Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. (2001) (68)
- Serum levels of the TGF-beta receptor are increased in atherosclerosis. (1996) (67)
- Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. (2006) (66)
- Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: Implications for increased vascular risk (1998) (66)
- Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre‐eclampsia (2001) (66)
- Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. (2002) (66)
- Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. (2006) (65)
- Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins? (2006) (64)
- Platelet‐derived VEGF, Flt‐1, Angiopoietin‐1 and P‐selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis (2004) (64)
- A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (2003) (63)
- Soluble markers of endothelial cell function. (1997) (61)
- Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis. (1999) (59)
- Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension. (2004) (59)
- Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome. (1998) (57)
- How a Damaged Blood Vessel Wall Contibutes to Thrombosis and Hypertenasion (2003) (56)
- A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation (2002) (56)
- Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. (2000) (55)
- Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls. (2000) (55)
- Inflammation and Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Effect of Treatment (2010) (55)
- Coronary risk factors, endothelial function, and atherosclerosis: a review. (1997) (54)
- Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteins. (1985) (54)
- Markers of inflammation in acute coronary syndromes: Association with increased heart rate and reductions in heart rate variability (2005) (54)
- von Willebrand factor, the endothelium and obesity. (1993) (54)
- von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia. (1997) (53)
- Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. (2000) (52)
- Increased circulating endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E‐selectin (2006) (51)
- Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease. (2001) (51)
- Angiogenesis in myocardial infarction. An acute or chronic process? (2002) (49)
- Circulating Endothelial Cells: Realities and Promises in Vascular Disorders (2003) (49)
- Endothelial integrity, soluble adhesion molecules and platelet markers in Type 1 diabetes mellitus (1998) (49)
- The Influence of Smoking and of Oral and Transdermal Nicotine on Blood Pressure, and Haematology and Coagulation Indices (1997) (49)
- Vascular endothelial lesion in patients undergoing bone marrow transplantation. (1996) (48)
- Increased Platelet Glycoprotein V Levels in Patients with Coronary and Peripheral Atherosclerosis (2001) (48)
- Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation (2005) (48)
- The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis (2008) (47)
- Soluble CD40L in peripheral artery disease (2005) (46)
- Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new ‘vascular triad’ (2004) (46)
- Microparticles and arterial disease. (2009) (46)
- Platelets and atrial fibrillation. (2001) (45)
- Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays. (2001) (45)
- Continuous retinal vessel diameter measurements: the future in retinal vessel assessment? (2010) (45)
- Endothelial cell damage and homocysteine. (1992) (45)
- Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus. (2003) (44)
- Effects of atorvastatin on circulating CD34+/CD133+/ CD45− progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus (2010) (44)
- Systemic inflammation increases shear stress‐induced platelet plug formation measured by the PFA‐100 (2000) (44)
- Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology? (2002) (44)
- Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma (2002) (43)
- Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplasty (1993) (43)
- Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease (2005) (43)
- Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease. (1995) (43)
- Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation (2005) (43)
- Left ventricular fibrosis in atrial fibrillation. (2013) (42)
- Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact? (2013) (42)
- Cell adhesion molecules in cardiovascular disease and its risk factors--what can soluble levels tell us? (2000) (42)
- Platelet activation, haemorheology and thrombogenesis in acute atrial fibrillation: a comparison with permanent atrial fibrillation (2003) (41)
- Angiogenic factors in atrial fibrillation: A possible role in thrombogenesis? (2005) (41)
- Anti‐oxidative properties of beta‐blockers and angiotensin‐converting enzyme inhibitors in congestive heart failure (2003) (41)
- Anticoagulation in hospitals and general practice (2003) (40)
- Soluble adhesion molecules, endothelial markers and atherosclerosis risk factors in abdominal aortic aneurysm: a comparison with claudicants and healthy controls (1998) (40)
- Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction (1999) (39)
- Low-Density Lipoprotein Subfractions and Cardiovascular Risk in Hypertension: Relationship to Endothelial Dysfunction and Effects of Treatment* (2002) (39)
- Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. (2004) (39)
- Plasma, platelet and erythrocyte glutathione peroxidases as risk factors in ischaemic heart disease in man. (1992) (39)
- Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension. (1999) (39)
- Effect of acute exercise on the raised plasma fibrinogen, soluble P‐Selectin and von willebrand factor levels in chronic atrial fibrillation (2001) (39)
- Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation (2011) (38)
- Prognostic value of plasma soluble P‐selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high‐risk patients with hypertension: a sub‐study of the Anglo‐Scandinavian Cardiac Outcomes Trial (2007) (38)
- Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis. (1996) (38)
- Plasma and Serum Von Willebrand Factor Antigen Concentrations in Connective Tissue Disorders (1992) (38)
- Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals (2002) (37)
- Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. (2004) (37)
- Platelet activation in pregnancy-induced hypertension. (2005) (37)
- ABC of antithrombotic therapy : Bleeding risks of (2002) (36)
- Venous thromboembolism (2006) (34)
- Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor (2011) (34)
- Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes (2005) (34)
- von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity. (1998) (33)
- Antihypertensive therapy and endothelial function. (2004) (33)
- Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients. (1999) (33)
- Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients (2006) (33)
- Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation. (2005) (33)
- An observational study of endothelial function in early arthritis (2012) (33)
- The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment (2005) (32)
- Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells (2003) (32)
- Salt intake and Helicobacter pylori infection (2004) (31)
- Effects of propofol and isoflurane on haemodynamics and the inflammatory response in cardiopulmonary bypass surgery (2015) (31)
- Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications (2013) (31)
- Prevalence of urinary and faecal incontinence among female members of the Hypermobility Syndrome Association (HMSA) (2009) (31)
- Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm (2001) (31)
- Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer (2004) (30)
- Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity (2003) (30)
- Increased soluble intercellular adhesion molecule-1, breast cancer and the acute phase response (2002) (30)
- Von Willebrand factor and soluble E‐selectin in hyperlipidaemia: Relationship to lipids and vascular disease (1997) (30)
- Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells (2003) (30)
- Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease. (2001) (29)
- Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction. (2008) (29)
- Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction. (2008) (28)
- Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt‐1, in haematological cancers: A comparison with breast cancer (2001) (28)
- Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment (2010) (28)
- Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients. (2006) (28)
- Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT) (2003) (28)
- Effect of the Antioxidants Selenium and Beta-carotene on HIV-related Endothelium Dysfunction (1998) (27)
- The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants (2009) (27)
- Circulating adhesion molecules in inflammatory and atherosclerotic vascular disease. (1995) (27)
- Laboratory monitoring of the non-vitamin K oral anticoagulants. (2014) (27)
- Increased circulating levels of von Willebrand factor antigen in smokers may be due to lipid peroxides (1991) (26)
- Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UK (2013) (26)
- Increased serum VEGF in 13 children with Wilms' tumour falls after surgery but rising levels predict poor prognosis. (2001) (26)
- Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure (2011) (26)
- Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study. (2011) (26)
- Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. (2007) (25)
- ABC of antithrombotic therapy (2003) (25)
- The acute influence of smoking on the endothelium. (1992) (25)
- Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer (2013) (25)
- Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease (2017) (24)
- Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study (2006) (24)
- Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: A comparison with plasma vascular markers (2011) (24)
- Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: relationship with von Willebrand factor. (1997) (24)
- Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis. (2010) (24)
- Increased non‐transferrin bound iron in plasma‐depleted SAG‐M red blood cell units (2002) (24)
- Von Willebrand factor, thrombomodulin, thromboxane, -thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis (24)
- Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction. (2007) (24)
- Increased Levels of Soluble Tumor Necrosis Factor Receptors in Atherosclerosis: No Clear Relationship with Levels of Tumor Necrosis Factor (1998) (24)
- Post-stroke inflammatory response: Effects of stroke evolution and outcome (2003) (24)
- ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study. (2009) (24)
- Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases. (2010) (24)
- Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. (2007) (23)
- Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project (2001) (23)
- Changes in von Willebrand factor and soluble ICAM, but not soluble VCAM, soluble E selectin or soluble thrombomodulin, reflect the natural history of the progression of atherosclerosis. (2002) (23)
- Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation (2016) (22)
- A contemporary viewpoint on ‘aspirin resistance’ (2012) (22)
- Circulating endothelial cells: from bench to clinical practice (2008) (22)
- Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men. (2000) (22)
- Thrombogenesis and fibrinolysis in acute coronary syndromes. Important facets of a prothrombotic or hypercoagulable state? (2000) (22)
- Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer (2011) (22)
- Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis (2002) (21)
- Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximisation study (BRUM) (2005) (21)
- Is raised von Willebrand factor a marker of endothelial cell damage? (1993) (21)
- Plasma haemoxygenase-1 in coronary artery disease (2010) (21)
- Normal levels of von Willebrand factor antigen in human body fluids. (1990) (21)
- Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit. (2011) (21)
- Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100 (2000) (21)
- von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease. (1993) (21)
- Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty. (2007) (21)
- Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype. (2006) (21)
- Altered blood vessel responses in the eye and finger in coronary artery disease. (2011) (20)
- Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. (2015) (20)
- The endotheliome: a new concept in vascular biology. (2011) (20)
- Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia. (2000) (20)
- Non-coding RNAs – A primer for the laboratory scientist (2019) (20)
- The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction. (2006) (20)
- Markers of endothelial cell activation and injury in childhood haemolytic uraemic syndrome (1999) (20)
- Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. (2007) (20)
- Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood (2006) (20)
- Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation (2015) (19)
- sFlt-1, a potential antagonist for exogenous VEGF. (2000) (19)
- von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair. (2000) (19)
- Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells. (2007) (19)
- The effect of statin therapy withdrawal on monocyte subsets (2013) (18)
- The influence of age and metformin treatment status on reported gastrointestinal side effects with liraglutide treatment in type 2 diabetes. (2015) (18)
- The Effect of Melatonin on Plasma Markers of Inflammation and on Expression of Nuclear Factor-Kappa Beta in Acetic Acid-Induced Colitis in the Rat (2013) (18)
- Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma (2004) (18)
- Soluble P-selectin, Thrombocytopenia and von Willebrand Factor in HIV Infected Patients (1997) (18)
- Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection. (2003) (18)
- Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo‐Scandinavian Cardiac Outcomes Trial (2007) (17)
- The effect of multi‐factorial intervention on plasma von Willebrand factor, soluble E‐selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease (2005) (17)
- THE PLATELET AND ENDOTHELIUM IN HIV INFECTION (1998) (17)
- Soluble p‐selectin should be measured in citrated plasma, not in serum (2003) (17)
- Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction (2000) (17)
- Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension (2005) (17)
- The effect of erythropoietin on platelet and endothelial activation markers: A prospective trial in healthy volunteers (2012) (17)
- Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen. (2001) (16)
- Circulating ICAM-1 in peripheral arterial disease as a predictor of adverse events (1998) (16)
- Endothelial function, platelet activation and coagulation in lower limb occlusive arterial disease during treadmill exercise: correlations with transcutaneous oxygen pressure. (2000) (16)
- Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation (2016) (16)
- Endothelial cell activation markers in cancer. (2012) (16)
- Enalapril Does Not Alter Adhesion Molecule Levels in Human Endotoxemia (2003) (15)
- Platelet adhesion in atrial fibrillation. (2007) (15)
- Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype (2008) (15)
- Vascular and platelet responses to aspirin in patients with coronary artery disease (2013) (15)
- Impact of High-Dose Atorvastatin on Endothelial, Platelet, and Angiogenic Indices (2011) (15)
- A pilot study of streptokinase‐induced endothelial injury and platelet activation following acute myocardial infarction (2000) (15)
- Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease. (2003) (15)
- Blood and hair lead in children with different extents of iron deficiency in Karachi. (2012) (15)
- Haematology and coagulation indices in paired samples of arterial and venous blood from patients with arterial disease. (1996) (14)
- Renal function and aspirin resistance in patients with coronary artery disease. (2012) (14)
- Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty (2000) (14)
- Plasma CX3CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project (2014) (14)
- Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patients. (1983) (14)
- The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study. (2010) (14)
- Non-vitamin K Antagonist Oral Anticoagulants (NOACs): a View from the Laboratory (2014) (14)
- von Willebrand factor: increased levels are related to poor prognosis in systemic sclerosis and not to tissue autoantibodies. (1997) (14)
- Platelet and haemorheological markers in ‘high risk’ hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT) (2004) (13)
- The angiome: a new concept in cancer biology (2011) (13)
- Increased levels of plasma haemoxygenase-1 in prostate cancer (2011) (13)
- Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study. (2019) (13)
- Increased membrane and soluble P-selectin in atrial fibrillation. (1999) (12)
- What is the purpose of liver function tests? (2014) (12)
- Vitamin E correlates inversely with non‐transferrin‐bound iron in sickle cell disease (2001) (12)
- Soluble P-selectin: the next step. (2014) (12)
- Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation (2014) (12)
- Endothelium‐dependent and endothelium‐independent vasodilatation of the cutaneous circulation in sickle cell disease (2011) (12)
- Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation. (2000) (12)
- Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology. (2009) (11)
- Distribution of lipid phenotypes in community-living men with coronary heart disease. (1993) (11)
- Cell adhesion molecules in cardiovascular disease: what can soluble levels tell us? (1999) (11)
- A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis. (2011) (11)
- Platelet activation as a marker of heart attack. (2011) (10)
- Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation. (2000) (10)
- Abnormal vascular, platelet and coagulation markers in primary thrombocythaemia are not reversed by treatments that reduce the platelet count (2004) (10)
- Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome (2015) (10)
- Immediate and late effects of coronary angiography on soluble endothelial cell markers and P-selectin in patients with and without coronary artery disease. (1999) (10)
- Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives. (2016) (10)
- Thromboembolic risk and pacemakers (1997) (10)
- Inflammation does not influence arterial stiffness and pulse-wave velocity in patients with coronary artery disease (2013) (10)
- Circulating endothelial cells in acute coronary syndromes. (2000) (10)
- Platelet adhesion in hypertension: Application of a novel assay of platelet adhesion (2005) (10)
- Validation of the Edinburgh Claudication Questionnaire in 1st generation Black African-Caribbean and South Asian UK migrants: A sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study (2011) (9)
- An update on vitamin D deficiency and at risk groups. (2015) (9)
- Development and validation of a new assay for assessing clot integrity. (2015) (9)
- von Willebrand factor antigen as an acute phase reactant and marker of endothelial cell injury in connective tissue diseases: a comparison with CRP, rheumatoid factor, and erythrocyte sedimentation rate. (1991) (9)
- Soluble Fas and Fas Ligand in Pregnancy (2012) (9)
- Plasma von Willebrand factor levels and surrogates of atherosclerosis (2005) (9)
- Ethnic background is a determinant of average warfarin dose required to maintain the INR between 3.0 and 4.5 (2004) (9)
- Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer. (2005) (9)
- Increased von Wilillebrand Factor antigen in Familial Iiypercholesterolaemia with or without vascular disease (1991) (9)
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension: relationship to cardiovascular risk and treatment (2004) (9)
- Circulating Endothelial Cells and Platelet Microparticles in Mitral Valve Disease With and Without Atrial Fibrillation (2015) (9)
- Angiogenesis and platelets: the clot thickens further. (2004) (9)
- Liraglutide pancreatitis: The ABCD nationwide liraglutide audit (2013) (9)
- Angiogenin and apoptosis in hypertension in pregnancy. (2011) (8)
- A Comparison of Plasma Versus Histologic Indices of Angiogenic Markers in Breast Cancer (2007) (8)
- Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism (2016) (8)
- Significance of Soluble P-Selectin, Von Willebrand Factor, and Other Adhesion Molecules in Hypercholesterolemia and Peripheral Artery Disease (1999) (8)
- Damage to the endothelium in Sjögren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB autoantigens. (1992) (8)
- Markers of Thrombosis and Hemostasis in Acute Coronary Syndromes: Relationship to Increased Heart Rate and Reduced Heart‐Rate Variability (2009) (8)
- The relationship of systemic markers of renal function and vascular function with retinal blood vessel responses (2016) (8)
- Venostasis, subclinical vasculitis and von Willebrand factor antigen. (1991) (8)
- Increased release of von Willebrand factor antigen by endothelial cells whilst in active growth phase. (1991) (8)
- Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer (2011) (8)
- Platelet adhesion in breast cancer: development and application of a novel assay (2004) (8)
- Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state? (2008) (8)
- Endothelial cell harbingers of adult respiratory distress syndrome in acute pancreatitis (1994) (8)
- Soluble platelet endothelial cell adhesion molecule-1 (sPECAM-1) in inflammatory vascular disease, atherosclerotic vascular disease, and in cancer. (1998) (8)
- Endothelial cell damage and the development or progression of atherosclerosis. (1999) (8)
- Vibration and induction of endothelial injury (1992) (8)
- Endothelium activation related increase of soluble intercellular adhesion molecule‐1 in human schistosomiasis. Lack of correlation with serology (1996) (7)
- Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis (2010) (7)
- Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function (2016) (7)
- Relation between endothelial-cell activation and infection, inflammation, and infarction (1997) (7)
- Influence of the Risk Factors for Atherosclerosis on Levels of Soluble Adhesion Molecules and Endothelial Markers in Peripheral Vascular Disease (2002) (7)
- Platelets: the universal killer? (2007) (7)
- Angiogenin and Hemoxygenase in Pregnancy (2012) (7)
- Thrombosis in clinical practice (2005) (7)
- Raised concentrations of von Willebrand factor antigen in systemic sclerosis. (1991) (7)
- Acute ingestion of red wine by men activates platelets but does not influence endothelial markers: no effect of white wine (2002) (7)
- Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: Differences in central versus peripheral levels (2007) (7)
- A reliable marker of vascular function: Does it exist? (2015) (6)
- Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers. (2000) (6)
- Atrial fibrillation and abnormalities of hemostatic factors. (2001) (6)
- Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer (2014) (6)
- Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis (2016) (6)
- Sunday, 26 August 2012 (2012) (5)
- Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease. (1999) (5)
- The detection of endothelial dysfunction in patients with essential hypertension. (1997) (5)
- Reduction in cholesterol is associated with reduction in Von Willebrand factor (1993) (5)
- Soluble intercellular adhesion molecule-1 in colorectal cancer and its relationship to acute phase proteins. (1996) (5)
- Ethnic/racial differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and cardiovascular disease. (2013) (5)
- Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation. (2003) (5)
- Assessment of endothelial function using plasma markers. (1997) (5)
- von Willebrand factor and atherosclerosis (1995) (5)
- To stroke or not to stroke (2003) (4)
- The endothelium and coagulopathy in systemic lupus erythematosus: hyperhomocysteinemia as a developing risk factor. (2003) (4)
- The Number of GT(n) Repeats in the Hemeoxygenase-1 Gene Promoter is Increased in Pediatric Heart Failure but is Unrelated to Renal, Antioxidant and Anti-inflammatory Markers (2015) (4)
- High von Willebrand factor antigen levels are associated with increased mortality in connective tissue diseases. (1992) (4)
- Hemostatic cardiovascular risk factors, common carotid–intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic‐Echocardiographic Heart of England Screening (E‐ECHOES) Study (2011) (4)
- Atherosclerosis risk factors: variation in healthy hospital workers and members of local communities asymptomatic for vascular disease. Implications for normal controls. (1995) (4)
- Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin (2016) (4)
- Vascular endothelial growth factor and platelets in primary (essential) thrombocythaemia (2005) (4)
- Helicobacter pylori seropositivity, lipid concentrations and haemostatic factors (2000) (4)
- Oxygen free radicals, reperfusion injury, endothelial cells, and von Willebrand factor. (1993) (4)
- Preventive Cardiology: Insights into the Prevention and Treatment of Cardiovascular Disease (2007) (4)
- Cell hybrids: an important new source of antibody production. (1979) (4)
- von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to vascular disease an the risk factors for atherosclerosis (1997) (4)
- British Journal of Biomedical Science in 2016. What have we learned? (2017) (4)
- British Journal of Biomedical Science in 2015: what have we learned? (2016) (4)
- Antihypertensive drug treatment and fibrinolytic function. (1998) (4)
- Why do we test for urea electrolytes? (2014) (4)
- Development and evaluation of a rapid, semi-automatic micro-method for ch50 estimation using a computor program (1990) (4)
- Functions and diseases of red and white blood cells. (2014) (4)
- von Willebrand factor antigen: a radial immunodiffusion method evaluated and compared with an ELISA method. (1992) (4)
- Angiogenesis, the metabolic syndrome and heart disease: is there a connection? (2010) (4)
- Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population. (2016) (4)
- Soluble P-selectin is influenced by cancer chemotherapy (2001) (3)
- O14 Vascular endothelial growth factor (VEGF) and soluble VEGF receptor (sFlt-1) levels in coronary artery disease and peripheral artery disease (1999) (3)
- Soluble adhesion molecules and coronary heart disease. Authors' reply (2002) (3)
- Liraglutide and acute pancreatitis in the Association of British Clinical Diabetologists (ABCD) nationwide liraglutide audit (2013) (3)
- Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease (2002) (3)
- Von Willebrand factor and forearm blood flow as indicators of endothelial dysfunction. (2004) (3)
- Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in (2015) (3)
- Chronic infections and coronary heart disease (1997) (3)
- Comprar Haematology | Gary Moore | 9780199568833 | Oxford University Press (2010) (3)
- Systemic and intracardiac vascular endothelial growth factor and angiopoietin‐1 and ‐2 levels in coronary artery disease: Effects of angioplasty (2007) (3)
- Endothelial Cell Markers and the Prediction of Cardiovascular Events (1997) (3)
- Soluble adhesion molecules and coronary heart disease (2002) (3)
- Indium 111 (111In) as a label for endothelial cells and fibroblasts used as target cells in cytotoxicity tests. (1985) (3)
- 2.P.180 Prognostic value of raised soluble thrombomodulin and soluble E-selectin in ischaemic heart disease (1997) (3)
- An assay for estimating the cytotoxicity of synovial fluid from patients with rheumatoid arthritis. (1985) (2)
- irculating Endothelial Cells in Cardiovascular Disease (2006) (2)
- Activated, cytotoxic lymphocytes in systemic vasculitis (2004) (2)
- Changes in von Willebrand Factor Antigen Levels in Venous Occlusion (1992) (2)
- Atrial fibrillation and thrombosis: the missing molecular links. (2013) (2)
- Good analytical practice: statistics and handling data in biomedical science. A primer and directions for authors. Part 1: Introduction. Data within and between one or two sets of individuals (2008) (2)
- Prevention and treatment of venous thromboembolism: the nurse's role in management (2014) (2)
- Soluble adhesion molecule P-selectin, von Willebrand factor and fibrinogen in acute stroke: Evidence for early endothelial and haemorheological dysfunction — the West Birmingham stroke project (1996) (2)
- Endothelial cell damage in rheumatoid disease correlates with complement consumption and immune complexes (2004) (2)
- Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm. (2005) (2)
- A randomised trial of carboplatin versus carboplatin and thalidomide in ovarian cancer, with evaluation of potential surrogate markers of angiogenesis. (2004) (2)
- Hyperhomocysteinaemia: a cardiovascular risk factor needing a large intervention trial? (1997) (2)
- Hematopathology: Genomic Mechanisms of Neoplastic Diseases (2011) (2)
- Prothrombotic factors and edothelial dysfunction in left ventricular hypertrophy: Implications for thrombogenesis and atherogenesis (1996) (2)
- British Journal of Biomedical Science in 2017: What have we learned? (2018) (2)
- Soluble adhesion molecules in NIDDM: Increased concentration, relation to glycometabolic control and possible pathophysiological significance (1996) (2)
- Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia. (2004) (2)
- Von Willebrand factor, thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systematic sclerosis. (1996) (2)
- Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease (2021) (2)
- Platelets in Thrombotic and Non-thrombotic Disorders: Platelet involvement in venous thrombosis and pulmonary embolism (2002) (2)
- Soluble E-selectin and soluble intercellar adhesion molecule-1 in coronary artery disease. (1998) (2)
- Comment: Raised Soluble P Selectin and the Risk of Thrombosis in HIV-1 Infection (2002) (2)
- Analysis of laboratory blood parameter results for patients diagnosed with COVID‐19, from all ethnic group populations: A single centre study (2021) (2)
- Raised levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the plasma of patients with ischaemic heart disease and hyperlipidaemia. (1998) (2)
- No Effect of Clopidogrel Activity or Cessation on Vascular Function or Markers of Inflammation (2012) (2)
- Factors influencing the frequency of attendance at a warfarin dosing clinic. (2001) (1)
- P15 Increased levels of soluble P selectin, a marker of platelet activation, in solid and haematological cancer (1999) (1)
- Endothelial Activation, Dysfunction and Damage in Congestive Heart Failure (2004) (1)
- Non-Vitamin K Oral Anticoagulants (NOACs) A Review of Clinical Management and Laboratory Issues. (2016) (1)
- Increased soluble ICAM-1 and IL-6 are not speciofic plasma markers of endothelial dysfunction. (2004) (1)
- Increased Levels of Soluble P Selectin and Von Willebrand Factor in Cancer: Influence of Radiotherapy and Surgery (1997) (1)
- Book Review: Prevention of recurrent heart attacks and strokes in low and middle income populations. Evidence-based recommendations for policy-makers and health professionals (2004) (1)
- 931 Platelet Activation in Non-Variceal Acute Upper Gastrointestinal Bleeding (2013) (1)
- Antiplatelet therapy and the vascular tree (2005) (1)
- Free Radicals, Antioxidants and Endothelial cell Damage following PTCA (1993) (1)
- 'Association of platelet function in hypertensive patients with left ventricular hypertrophy'. (1999) (1)
- Left atrial thrombin generation and prothrombin fragment 1+2. (2000) (1)
- Angiogenesis in Atherosclerosis: Possible Roles for Vascular Endothelial Cell Growth Factor, Endothelial Cell Stimulating Angiogenesis Factor and Soluble E-Selectin (1998) (1)
- Reduced antioxidant capacity in hypercholesterolaemic patients with vascular disease (1993) (1)
- Plasma thrombomodulin in atherosclerosis and its risk factors. (1997) (1)
- The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease (2014) (1)
- PLATELET FUNCTION IN CORONARY ARTERY DISEASE: DEFINING RESPONSE TO ANTIPLATELETS (2008) (1)
- W04.140 Plasma VEGF and angiopoietins in diabetes: Relationship with endothelial damage/dysfunction and atherosclerosis and effect of multifactorial intervention (2004) (1)
- Endothelial damage and adhesion molecules ICAM, VCAM and E-selectin in acute stroke (1996) (1)
- Increased levels of soluble P-selectin correlate with iron overload in sickle cell disease (2007) (1)
- Blood Science Principles and Pathology Blood Science Principles and Pathology (2014) (1)
- Platelet and endothelial-cell markers in meningococcal septicaemia: a report of two cases. (2001) (1)
- British Journal of Biomedical Science in 2018: what have we learned? (2018) (1)
- The rolling evolution of biomedical science as an essential tool in modern clinical practice (2016) (1)
- von Willebrand factor, exercise, and ischemia/reperfusion injury. (1993) (1)
- Neutrophil leucocytosis in atherosclerosis. (1997) (1)
- Investigation of soluble adhesion molecules in cancer: beneficial approach or expensive toy? The case of intercellular adhesion molecule-1 (sICAM-1) (1994) (1)
- Soluble P-selectin in Diabetes (1999) (1)
- Tamoxifen for breast-cancer prevention (2003) (1)
- Coronary risk factors, endothelial function, and atherosclerosis: A review: To the editor (1997) (1)
- Erratum: Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer (British Journal of Cancer (2011) 104 (1822-1827) DOI:10.1038/bjc.2011.154) (2011) (1)
- PWE-161 Platelet activation in acute upper gastrointestinal bleeding (2012) (1)
- Bilirubin is Cytotoxic to Endothelial Cells in VITRO and in VIVO (1992) (1)
- W03-P-002 Circulating endothelial cells, Von Willebrand factor and flow mediated dilatation as indices of endothelial damage/dysfunction in patients with acute (2005) (1)
- Blood tests and age-related changes in older people. (2014) (1)
- Endothelial dysfunction and platelet activation in patient with chronic atrial fibrillation: interactions leading to thrombogenesis? (1998) (0)
- Ethnic differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and peripheral arterial disease (2011) (0)
- Good analytical practice: statistics and handling data in biomedical science: A primer and directions for authors. Part 2: Analysis of data from three or more groups, and instructions for authors (2009) (0)
- Platelet, coagulation and endothelial markers in primary thrombocythaemia (2003) (0)
- Human monoclonal antibodies: their technology and application. (1981) (0)
- 0-91. Serum vascular endothelial cell marker (VCAM) and e-selectin (Esel) are endothelial markers for angiogenesis in early and advanced breast cancer (1997) (0)
- Letters (1999) (0)
- Thanks to Reviewers (2006) (0)
- Thanks to Reviewers (2016) (0)
- P-95: Does pulse pressure influence the hypercoagulable state in nonvalvular atrial fibrillation? (2001) (0)
- Increased platelet adhesion in metastatic cancer (2003) (0)
- Damage totheendothelium inSjogren's syndrome: lackofcorrelation withantinuclear antibody titre andpresenceofantibodies toSSAor SSB autoantigens (1992) (0)
- Plasma markers of endothelial dysfunction in dyslipidaemic patients: Outcome after a 3-months treatment (2000) (0)
- Angiogenesis and endothelial damage in acute myocardial infarction: an acute or chronic process? (2001) (0)
- P-90: Soluble P-selectin, a marker of platelet activation, is related to plasma homocyst(e)ine in ‘high risk’ hypertensives (2001) (0)
- Menstrual immunisation. (1991) (0)
- Abstract (2007) (0)
- Which is the ideal plasma marker of endothelial damage/dysfunction in atrial fibrillation? A comparison of von Willebrand factor, E-selectin and soluble thrombomodulin (2003) (0)
- Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men. (1998) (0)
- P80. Antioxidant supplements protect against endothelial damage in HIV infection (1996) (0)
- LEFT VENTRICULAR MASS AND DIASTOLIC FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE WITH AND WITHOUT HYPERTENSION: RELATIONSHIP TO ENDOTHELIAL DAMAGE/DYSFUNCTION (2004) (0)
- Increased levels of plasma glycoprotein V in peripheral and coronary artery disease (2001) (0)
- P3 Racial background is a determinant of Warfarin use (1998) (0)
- Hypertension latelet Indexes in Relation to Target rgan Damage in High-Risk Hypertensive Patients Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial ( ASCOT ) unil (2016) (0)
- hyperhomocysteinemia as a developing risk factor . The endothelium and coagulopathy in systemic lupus erythematosus : (2003) (0)
- Book Reviews (2007) (0)
- 11 Von Willebrand factor antigen and hypertension (1991) (0)
- Von willebrand factor plasma concentration raises after a load in methionin in hyperhomocysteinaemic patients (1999) (0)
- Molecular Hematology (2011) (0)
- Tamoxifen for breast-cancer prevention. Authors' reply (2003) (0)
- Book Reviews (2012) (0)
- Coagulation inhibitors and glycaemic control in non-insulin-dependent diabetes mellitus (1994) (0)
- 1161-175 Platelet-derived vascular endothelial growth factor in patients with hypertension: Relationship to platelet activation and plasma indices of angiogenesis (2004) (0)
- Does intensive antihypertensive therapy have an effect on von Willebrand factor as an index for vascular damage and vascular endothelial growth factor as an index for angiogenesis (2001) (0)
- 18Effect of warfarin and rivaroxaban on clot structure (2014) (0)
- ABNORMAL FIBRIN CLOT STRUCTURE IN ATRIAL FIBRILLATION (2014) (0)
- Monoclonal Antibodies — Biotechnology and Medical Applications (1988) (0)
- Retinal arteriolar diameter response to flicker light provocation - A useful marker for risk stratification in cardiovascular disease? (2013) (0)
- 826 Abnormal platelet activation, adhesion and function in systolic heart failure (2005) (0)
- Relationship of Angiopoietin-1 and −2 (Ang-1 and −2), Vascular Endothelial Growth Factor (VEGF) and Von Willebrand Factor (vWf) to Endothelial Damage in Congestive Heart Failure (CHF) (2004) (0)
- Thanks to Reviewers (2002) (0)
- 196. BONE MARKER RESPONSE IN CHRONIC DIFFUSE SCLEROSING OSTEOMYELITIS TREATED WITH IBANDRONATE (2006) (0)
- Haematocrit and plasma viscosity in atrial fibrillation. (2000) (0)
- Corrigendum to: ‘The adhesion molecule P-selectin and cardiovascular disease’ [Eur Heart J 2003;24:2166–2179] (2006) (0)
- Tamoxifen for breast-cancer prevention [3] (multiple letters) (2003) (0)
- Detection an dq uantification of matur ec irculating endothelial cell s using flo wc ytometr ya nd immunomagnetic beads: Am ethodological comparison (2006) (0)
- 058 The relationship of left atrial remodelling to atrial fibrillation burden in pacemaker population (2012) (0)
- Research: Treatment The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study (2013) (0)
- Immunogold cell labelling system for T lymphocyte enumeration: an evaluation. (1986) (0)
- O4 Endothelial cell markers and the prediction of arterial stenosis in peripheral and carotid artery disease (1998) (0)
- Endothelial cell damageinprimary biliary cirrhosis: influence ofcholestasis andimmunological mechanisms (1992) (0)
- von Willebrand factor in synovial fluid: a comment. (1992) (0)
- The effect of running a marathon on routine and research vascular, hematology and biochemistry indices (2003) (0)
- The Journal of Rheumatology dysfunction in systemic lupus erythematosus. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell (2003) (0)
- P-412: Relationship of von Willebrand factor, an index for endothelial damage, and vascular endothelial growth factor, an index of angiogenesis to cardiovascular and cerebrovascular risk scores based on the framingham equation (2001) (0)
- Book Review: 3. Progress against heart disease (2005) (0)
- P78. Endothelial activation and inflammatory markers following bone marrow transplantation (1996) (0)
- A special thanks to our reviewers for 2013. (2014) (0)
- A Phase II Study of Razoxane , an Antiangiogenic Topoisomerase II Inhibitor , in Renal Cell Cancer with Assessment of Potential Surrogate Markers of Angiogenesis 1 (2000) (0)
- ABCD position statement on GLP‐1 based therapies and pancreatic damage (2013) (0)
- Thanks to Reviewers (2018) (0)
- H001: Does blood pressure influence the hypercoagulable state in atrial fibrillation? (1999) (0)
- Adhesion molecules in cardiovascular disease: opportunities for new therapeutic directions? (1998) (0)
- Endothelial Cell Markers and the Extent of Symptomatic Atherosclerosis (1997) (0)
- Positive effect of a low dose combination of perindopril/ indapamide on the d-dimers and the endothelial factors in hypertensive patients (2004) (0)
- Effects of intensive cardiovascular risk factor management on endothelial function and angiogenesis in ‘high risk’ hypertensive patients (2002) (0)
- 403 sPsel commentary Thromb Res (2014) (0)
- Contents Vol. 33 (2003) (0)
- Author's reply (1993) (0)
- Rowing and Redgrave (2009) (0)
- OR-6: Effects of treatment on endothelial function, angiogenesis and thrombogenesis in hypertension (2002) (0)
- O13 The effect of acute smoking on platelet aggregometry and alpha granule degranulation (1999) (0)
- Author Response: Can Vascular Function Be Assessed by the Interpretation of Retinal Vascular Diameter Changes? (2011) (0)
- Acknowledgment to Reviewers (2017) (0)
- Soluble adhesion molecule P-selectin and beta-thromboglobulin as markers of platelet activation in hypertension (1998) (0)
- Progress against Heart Disease (2005) (0)
- A RANDOMISED PHASE TWO STUDY OF CARBOPLATIN VERSUS CARBOPLATIN AND THALIDOMIDE IN PATIENTS WITH OVARIAN CANCER, WITH EVALUATION OF POTENTIAL SURROGATE MARKERS OF ANGIOGENESIS (2004) (0)
- Book Review: Preventive cardiology: insights into the prevention and treatment of cardiovascular disease (2007) (0)
- Thrombogenesis, angiogenesis, and endothelial function in hypertension (2002) (0)
- RAISED CIRCULATING ENDOTHELIAL CELLS IN RHEUMATOID AND EARLY ARTHRITIS (2007) (0)
- Red wine: can you have too much of a good thing? (2009) (0)
- 512 ETHNIC DIFFERENCES IN CIRCULATING MARKERS OF ANGIOGENESIS AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS AND PERIPHERAL ARTERIAL DISEASE (2011) (0)
- Thanks to reviewers (2014) (0)
- von Willebrand factor in upper gastrointestinal tract inflammation. (1993) (0)
- Retinal vessel parameters in obstuctive sleep apnea (2016) (0)
- Chapter 14 – The Endothelium in Hypertension: Assessment and Clinical Aspects of Micro- and Macrovascular Function (2007) (0)
- W03-O-001 Increased numbers of circulating endothelial cells predict adverse cardiovascular events following an acute coronary syndrome (2005) (0)
- Synovial fluid acid phosphatase in rheumatoid arthritis. (1991) (0)
- Hemostatic abnormalities associated with obesity and the metabolic syndrome (2005) (0)
- Biomarker of vascula rd isease (2005) (0)
- Book Reviews (1850) (0)
- Aspirin reduces platelet vascular endothelial growth factor and angiopoietin-1 (2004) (0)
- Angiogenesis and Endothelial Growth Factor in Atherosclerosis (1997) (0)
- P-647: Endothelial damage and angiogenesis in high-risk hypertesive patient: Relation to risk factors (2001) (0)
- Diurnal rhythms and hemostatic factors in atrial fibrillation: reply (2001) (0)
- W03-P-003 Circulating endothelial cells in acute ischaemic stroke (2005) (0)
- British Journal of Biomedical Science in 2019. What have we learned? (2019) (0)
- Raised arterial blood pressure exacerbates diastolic dysfunction in diabetes mellitus independent of atherosclerosis (2004) (0)
- Commonly used anticoagulant and antiplatelet drugs: aspirin, heparin and warfari (2005) (0)
- List of reviewers for 2007 (2007) (0)
- Three-months supplementation with folic acid and vitamin B6 decreases endothelium injury in hyperhomocysteinaemic patients (1999) (0)
- Antioxidant Status in Hypertension and Its Relationship with Endothelial Damage (1994) (0)
- A randomised trial of carboplatin versus carboplatin and thalidomide in ovarian cancer, with evaluation of potential surrogate markers of angiogenesis (2004) (0)
- P-91: ‘High risk’ hypertensive patients with target organ damage exhibit elevated markers of platelet and endothelial function (2001) (0)
- Development and evaluation of a rapid, semi-automatic micro-method for CH50 estimation using a computer program. (1990) (0)
- A procoagulant state and endothelial dysfunction in obese children (2013) (0)
- Relationship of platelet P-selectin levels and platelet morphology to platelet activation in hypertensives (2003) (0)
- Plasma metalloproteinase-9 in age-related macular degeneration (2009) (0)
- Soluble Pecam in Cancer Atherosclerosis, and Connective Tissue Diseases (1998) (0)
- Endothelial Biomedicine: Circulating Markers of Endothelial Function (2007) (0)
- University of Birmingham Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation (2016) (0)
- Physical activity in relation to endothelial dysfunction and angiogenesis in hypertension (2002) (0)
- P-277: A comparison of flow mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension (2002) (0)
- A modification of the natural killer cell assay by substitution of 111indium for 51chromium. (1987) (0)
- Von Willebrand Factor (VWF), E-Selectin (E-SEL) and Soluble Thrombomodulin (STM) as Markers of Endothelial Damage/Dysfunction in Paroxysmal, Persistent and Permanent Atrial Fibrillation (AF) (2004) (0)
- Recombinant DNA technology in haematology. (1988) (0)
- Retinal vessel geometry and oxygen saturation in patients suffering from diabetes mellitus and/ or cardiovascular disease (2017) (0)
- Diagnosis, treatment and management of venous thromboembolism: recent developments relevant to biomedical scientists (2007) (0)
- Cerebral Hypoxia and Cellular Activation in Carotid Endarterectomy (1995) (0)
- CARDIOVASCULAR GENOMIC MEDICINE Circulating Endothelial Cells in Cardiovascular Disease (2006) (0)
- T lymphocyte surface molecules: structure and function. (1987) (0)
- C0410: Hemostatic Derangements in Patients Undergoing Open and Endovascular Repair of Abdominal Aortic Aneurysms (2014) (0)
- Vascular endothelial growth factor, soluble receptor Flt-1 and von willebrand factor in coronary artery disease: relationship to disease severity (2001) (0)
- Recombinant CRP induces increased release of ICAM and thrombomodulin, but not vWF or E selectin, from HUVECs (2001) (0)
- Genetics of the HLA system. (1988) (0)
- P2 Increased soluble P selectin in subjects with deep vein thrombosis (1998) (0)
- Does Hypertension Confer a Prothrombotic State? (1999) (0)
- Serum soluble VCAM: A surrogate marker of angiogenesis (1998) (0)
- Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate (2012) (0)
- W03-P-001 Increased circulating endothelial cells in acute congestive heart failure: Comparison (2005) (0)
- Endothelial Damage/Dysfunction is Independently Associated with Diastolic Dysfunction in Diabetes (2004) (0)
- Von Willebrand Factor, Hyperlipidaemia, and Vascular Disease (1992) (0)
- P-260: Impact of blood pressure on coronary artery disease severity, endothelial damage and angiogenesis (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrew D. Blann?
Andrew D. Blann is affiliated with the following schools:
